ASTRAZENECA said on Tuesday (Feb 6) it will invest US$300 million in a facility in Rockville, Maryland, for discovery and development of cell therapies.
AstraZeneca to invest US$300 million in US facility for cell therapies
2024-02-06T15:15:04-05:00February 6th, 2024|
Related Posts
-
Delfi Q1 Ebitda falls 8.5% on lower net sales
May 28th, 2024 -
Daily Debrief: What Happened Today (May 28)
May 28th, 2024 -
Wall Street returns to T+1 stock trading after a century
May 28th, 2024